AU6657396A - Transdermal system - Google Patents

Transdermal system

Info

Publication number
AU6657396A
AU6657396A AU66573/96A AU6657396A AU6657396A AU 6657396 A AU6657396 A AU 6657396A AU 66573/96 A AU66573/96 A AU 66573/96A AU 6657396 A AU6657396 A AU 6657396A AU 6657396 A AU6657396 A AU 6657396A
Authority
AU
Australia
Prior art keywords
transdermal system
transdermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU66573/96A
Other languages
English (en)
Inventor
Steffen Lang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Novartis AG filed Critical Ciba Geigy AG
Publication of AU6657396A publication Critical patent/AU6657396A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
AU66573/96A 1995-07-28 1996-07-17 Transdermal system Abandoned AU6657396A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP95810488 1995-07-28
EP95810488 1995-07-28
PCT/EP1996/003148 WO1997004835A1 (de) 1995-07-28 1996-07-17 Transdermales system

Publications (1)

Publication Number Publication Date
AU6657396A true AU6657396A (en) 1997-02-26

Family

ID=8221778

Family Applications (1)

Application Number Title Priority Date Filing Date
AU66573/96A Abandoned AU6657396A (en) 1995-07-28 1996-07-17 Transdermal system

Country Status (2)

Country Link
AU (1) AU6657396A (de)
WO (1) WO1997004835A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
EP0913152B1 (de) * 1997-11-03 2001-12-19 Stada Arzneimittel Ag Stabilisiertes Kombinationsarzneimittel enthaltend Naloxone und ein Opiatanalgetikum
US6136327A (en) * 1997-12-01 2000-10-24 Alza Corporation Stereospecific delivery of a drug using electrotransport
PT2062573E (pt) * 2001-05-01 2012-01-11 Euro Celtique Sa Sistemas transdérmicos que contêm opióides que resistem a violação
ES2361068T3 (es) * 2002-04-23 2011-06-13 Durect Corporation Sistemas analgésicos transdérmicos con potencial de abuso reducido.
EP1513532B1 (de) * 2002-06-10 2007-02-28 Euro-Celtique S.A. Entsorgungssysteme für transdermale abgabevorrichtungen zur verhinderung des missbrauchs von darin enthaltenen wirkstoffen
US20040219195A1 (en) * 2003-04-30 2004-11-04 3M Innovative Properties Company Abuse-resistant transdermal dosage form
JP5048324B2 (ja) * 2003-04-30 2012-10-17 パーデュー、ファーマ、リミテッド、パートナーシップ 活性物質要素および該活性物質レイヤーの遠位に副作用物質要素を含む耐タンパー性経皮剤形
US7182955B2 (en) 2003-04-30 2007-02-27 3M Innovative Properties Company Abuse-resistant transdermal dosage form
TW200640526A (en) * 2005-02-24 2006-12-01 Alza Corp Transdermal electrotransport drug delivery systems with reduced abuse potential

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL105073A0 (en) * 1992-03-17 1993-07-08 Becton Dickinson Co User activated iontophoretic device and method for using same
FR2709423B1 (fr) * 1993-08-30 1995-11-17 Lhd Lab Hygiene Dietetique Réservoir imprégnable d'une solution de principe actif, pour dispositif ionophorétique d'administration transdermique de médicaments, et procédé de fabrication d'un tel réservoir.
US5533971A (en) * 1993-09-03 1996-07-09 Alza Corporation Reduction of skin irritation during electrotransport

Also Published As

Publication number Publication date
WO1997004835A1 (de) 1997-02-13

Similar Documents

Publication Publication Date Title
AU7310696A (en) Dsplay system
AU7135196A (en) Transdermal matrix system
AU4605496A (en) Fastening system
AU7163796A (en) Security system
AU5235796A (en) o-hydroxyphenyl-s-triazines
AU4780896A (en) Core-board
AU1030997A (en) Taphane
AU3539297A (en) Transdermal therapeutic systems
AU4996696A (en) 2-benzyl-3-arylbenzothiophenes
AU5147496A (en) Fucopeptides
AU6657396A (en) Transdermal system
AU5500196A (en) Anti-transpirants
AU4382896A (en) Acetylimidazobenzodiazepines
AU4396396A (en) Baby-bathing aid
AU5108596A (en) Morphine-3-esters
AU1322497A (en) Computing system
AU5013796A (en) Wireclamp
AU5107096A (en) Haemodialyser
AU5404996A (en) Construction system
AU7345296A (en) Anchor system
AU4569496A (en) Tetralinyl- and indanyl-ethylamides
AU5597696A (en) Treatment system
AU4726796A (en) Massage system
AU2609095A (en) Compartmentalizer
AU2161897A (en) Helicopter-airplane